The American Society of Anesthesiologists requires ETCO₂ monitoring during deep to moderate sedation. Doing so can reduce hypoxic events by approximately 40% compared to standard monitoring alone.¹ Real-time CO₂ tracking helps clinicians detect respiratory depression before oxygen saturation levels drop, enhancing patient safety.

Unfortunately, current ETCO₂ monitoring methods are unreliable.

The AERIS Airway™ from Airway Innovations transforms standard oropharyngeal (OPAS) and nasopharyngeal (NPAs) airways into advanced dual-function systems that deliver better oxygenation while capturing reliable ETCO₂ data in real-time, helping clinicians maintain safer sedation airway management.

Precise Oxygen Delivery Meets Reliable CO₂ Monitoring

Unlike traditional setups, AERIS offsets the oxygen delivery port from the CO₂ detection port. This allows for accurate ETCO₂ monitoring at the supraglottis with minimal oxygen dilution. This results in a clear, reliable waveform on standard capnography monitors while maintaining a smooth laminar oxygen flow through the airway device.

The AERIS is compatible with 95 percent of adult Guedel OPAs and NPAs. It can deliver high concentrations of oxygen efficiently, reaching up to 80 percent FiO₂ at low rates and up to 100 percent at moderate flow rates. Optimizing oxygen delivery and reducing dilution, clinicians can maintain adequate oxygenation while using less oxygen overall.

The AERIS Airway™ sets a new standard in I.V. sedation by improving patient safety and workflows, lowering morbidity risk, decreasing overall oxygen consumption, and helping to reduce costs.

Key Features of the AEIRS Airway™

• Dual Function Design – Simultaneously delivers oxygen and captures reliable ETCO₂ data in real time
• Offset Port Technology – Minimizes oxygen dilution for more accurate CO₂ waveform monitoring
• High FiO₂ Capability – Delivers up to 80% FiO₂ at 2–4 L/min and up to 100% at 6–10 L/min
• Broad Compatibility – Fits 95% of adult Guedel OPAs and NPAs
• Laminar Flow Oxygen Delivery – Promotes efficient oxygenation with lower overall oxygen use
• Enhanced Patient Safety – Supports earlier detection of respiratory compromise
• Workflow Efficiency – Modernizes standard airway devices without adding complexity

For more information or a demonstration of the AERIS Airway™, contact your local MED Alliance Group sales representative, call 888-891-1200 or email us.

MED Alliance Group is a medical device distributor dedicated to meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, as well as NICU and PICU.

Please follow us on LinkedIn, Facebook and Twitter for MED Alliance product updates.

Reference:

¹Deitch K, Miner J, Chudnofsky CR, Dominici P, Latta D. Does end tidal CO2 monitoring during emergency department procedural sedation and analgesia with propofol decrease the incidence of hypoxic events? A randomized, controlled trial. Ann Emerg Med. 2010 Mar;55(3):258-64. doi: 10.1016/j.annemergmed.2009.07.030. Epub 2009 Sep 24. PMID: 19783324.